4099.0: Tuesday, November 14, 2000: 12:30 PM-2:00 PM

Monitoring HIV, HPC, and Injection Drug Users Issues I

See individual abstracts for presenting author's disclosure statement.
Learning Objectives: Refer to the individual abstracts for learning objectives
Board 1Hepatitis C virus (HCV) antibody testing, follow-up, and clinical management among in treatment drug users: A preliminary report from a San Francisco methadone maintenance (MMT) program
M. Patricia Perkins, MS, Laurene Spencer, MD, Audrey Sellers, MD, Layla Alpers, MS, William Shore, MD, Adil Ed Wakil, MD, Don Des Jarlais, PhD, Allen Frank, MD
Board 2Hepatitis A among injection drug users in Anchorage, Alaska
Rebecca S. Wells, SM, Dennis G. Fisher, PhD, Andrea M. Fenaughty, PhD, Henry H Cagle, BS
Board 3Does needle exchange cause an increase in drug use?
Dennis G. Fisher, PhD, Ramon C. Littell, PhD, Andrea M. Fenaughty, PhD, Carol Bigelow, PhD, Henry H Cagle, BA
Board 4Access to and utilization of appropriate HIV care among positive injection drug users
Starley B. Shade, MPH, Carol Dawson-Rose, RN, PhD, Kelly Ray Knight, MA, Cynthia Gomez, PhD, the Seropositive Urban Drug Injectors Study Team
Board 5Characteristics of injection drug users who utilize tuberculosis services at sites of the Baltimore City needle exchange program
Elise D. Riley, MPH, David Vlahov, PhD, Peter Beilenson, MD, MPH, Richard E. Chaisson, MD, MPH
Board 6Declines in Diagnosed HIV Infections Among Injection Drug Users, 25 HIV Reporting States, United States, 1994 – 1998
Tadesse Wuhib, MD, MPH, Jianmin Li, DPE, Pascale Wortley, MD, MPH
Board 7Disparities in public health service utilization and need of HIV-positive substance users: Results of a statewide assessment
John Brion, RN, MS, Amy Davis, MPH, CHES
Board 8Declining HIV seroincidence among injection drug users in San Francisco, 1986-1997
Alex H. Kral, PhD, Peter Bacchetti, PhD, Lauren Gee, MPH, Jennifer Lorvick, BA, Ricky N. Bluthenthal, PhD, Brian R. Edlin, MD
Board 9Gender Differences in HIV Risk Behaviors among Puerto Rican Drug Injectors by Awareness of HIV Seropositive Status
Sung-Yeon Kang, PhD, Sherry Deren, PhD, Jonny Andía, Hector M. Colón, Rafaela R. Robles, PhD
Board 10Gender differences in injection behavior among IDUs in Anchorage, Alaska
Andrea M. Fenaughty, PhD, Dennis G. Fisher, PhD, Carol Bigelow, PhD
Sponsor:Alcohol, Tobacco, and Other Drugs
Cosponsors:Epidemiology; HIV/AIDS SPIG; Social Work

The 128th Annual Meeting of APHA